Ultragenyx Pharmaceutical | RARE - Loan Capital

Stock Price
24.67
Daily Change
0.88 3.70%
Monthly
1.94%
Yearly
-45.60%
Q1 Forecast
23.33

Ultragenyx Pharmaceutical reported $782.75M in Loan Capital for its fiscal quarter ending in June of 2025.





Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Mar/2025
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Alnylam Pharmaceuticals USD 1.04B 13.75M Sep/2025
BioMarin Pharmaceutical USD 596.66M 501K Sep/2025
Insmed USD 539.72M 21.23M Sep/2025
Ionis Pharmaceuticals USD 28.78M 596.71M Sep/2025
Kyowa Hakko Kirin JPY 24.12B 5.27B Dec/2024
MacroGenics USD 70.26M 4K Sep/2025
Moderna USD 26M 6M Sep/2025
Neurocrine Biosciences USD 169.5M 500K Mar/2023
PTC Therapeutics USD 1.84B 298.68M Sep/2025
Regeneron Pharmaceuticals USD 2.71B 720.4M Dec/2025
Sarepta Therapeutics USD 1.04B 104.31M Sep/2025
Ultragenyx Pharmaceutical USD 782.75M 11.3M Jun/2025
Vertex Pharmaceuticals USD 111.4M 1.4M Mar/2025